₹562.4
+1.47% today
· 30d -7.65%
as of 2026-09-04
Price · Daily Candles
“PGEL's Earnings Surge Amidst Sector Headwinds, DIIs Accumulate as Stock Slides.”
PGEL reported robust Q4 2025 results, with net profit up 56.68% YoY and revenue up 45.93% YoY, driving full-year 2025 net profit growth of 113.34%. Despite this financial performance, the stock has seen significant price declines, down 43.23% over the last year, trading near its 52-week low of ₹436.55, and is currently bearish on technical indicators.
BULL CASE
+Q4 2025 net profit soared by 56.68% YoY to ₹62 Cr, showcasing strong operational leverage.
+Annual revenue witnessed a 76.46% YoY increase to ₹4870 Cr in 2025, demonstrating accelerated top-line growth.
+The company boasts impressive 3-year and 5-year net profit CAGRs of 97.4% and 156.05% respectively, pointing to sustained historical growth.
+ML predictions indicate strong Frees Cash Flow (FCF) stability over 7 years (rank 0.762) and good sales stability over 7 years (rank 0.674).
BEAR CASE
−The stock price has plummeted by 43.23% over the last year and is currently trading near its 52-week low of ₹436.55, with a 3-month return of -25.59%.
−FIIs decreased their stake by 0.85% QoQ to 9.74% in Q4 2025.
−Despite strong profit growth, the company is free cash flow negative, with a current FCF yield of -4.24%, indicating high cash consumption.
−Technical indicators like MACD (-3.8081) and RSI (35.46) are bearish, suggesting further price weakness.
⟳ What Changed
₹ Latest Earnings · Q ending 2025-12-31
REVENUE
₹1412 Cr
+45.93% YoY
NET PROFIT
₹62 Cr
+56.68% YoY
OPM
8.87%
-0.6pp YoY
EPS
₹2.18
PE 47.65
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-3.5% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PGEL trades at a TTM P/E of 47.65 with a ROCE of 19.0%, making it relatively more attractive on valuation than peers like AVALON (P/E 86.41, ROCE 19.72) and KRN (P/E 88.34, ROCE 16.44) but still higher than KAYNES (P/E 60.77, ROCE 17.65) and SYRMA (P/E 64.09, ROCE 18.63).
PEERPEROCE %
PGEL47.6519.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
58
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
75
Valuation
FAIR
40
Growth
STRONG
84
Profitability
DECENT
68
Technicals
NEUTRAL
50
Risk
ELEVATED
30
Key Stats
TTM PE
47.65
P/B
4.93
52W HIGH
₹644.4
OFF HIGH
-12.73%
DIV YIELD
0.05%
MKT CAP
₹16061 Cr
◉ Active Signals
MACDBearish-5.8278
RSI(14)Bearish37.27
Street Consensus
8 analysts₹695.38
mean target
Low ₹610.0Now ₹562.4High ₹825.0
⧉ Strategy Fit 🔒